XBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Xenetic Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.93−0.06 (-3.02%)
Close on Oct 19, 2026
- Market cap
- $4.43M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Xenetic Biosciences's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 23, 2026 | Sep 23, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 14, 2026 | Sep 16, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2026 | Aug 7, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | May 13, 2026 | May 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 12, 2026 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2025 | Apr 24, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 21, 2026 | Apr 24, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 13, 2026 | Mar 13, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2026 | Jan 9, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2025 | Dec 11, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 11, 2025 | Oct 31, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 10, 2025 | Oct 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2025 | Aug 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2024 | May 13, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2024 | Apr 29, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 8, 2025 | Apr 10, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2025 | Mar 19, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 18, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2024 | Dec 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 1, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2024 | Oct 31, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 11, 2024 | Oct 31, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2024 | Aug 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2024 | Jun 21, 2024 | SEC EDGAR |
| Current report | 8-K | May 16, 2024 | May 22, 2024 | SEC EDGAR |
| Current report | 8-K | May 10, 2024 | May 10, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 9, 2024 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2023 | Apr 26, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 22, 2024 | Mar 22, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 21, 2024 | SEC EDGAR |